-
Published on Aug 1, 2016
Life
sciences group TyraTech Inc (LON:TYR) says it has shown strong growth
against market competitors, an increased product line and an expanding
distributor network ahead of first half results.
“All of these factors combined to make us the leading brand of head lice treatment,” says chief executive Bruno Jactel.
"These trends are anticipated to continue throughout the second half."
But it hasn’t all been smooth sailing, explains Jactel, especially with the referendum.
“Of course it came as a surprise for us, we had not planned for the Brexit vote, so we have been challenged by changes in exchange rates between the pound and the dollar, so that’s hurting our UK sales when we transfer them into dollars,” he says.
“But that doesn’t affect our underlying business in the UK. When we look at that in pounds it shows strong growth and market gain,” adds Jactel.
He says the group has had to adapt to changes in policies with big retail distributors, particularly in the US.
“We’ve been able to adapt well,” he says.
“So far what we are seeing, besides the little glitch, is a strong and healthy business.”
http://www.4-traders.com/TYRATECH-INC-4007092/
No comments:
Post a Comment